Willow Biosciences Inc. (Willow), a biotechnology company, has announced a significant partnership with Laurus Labs, a pharmaceutical and biotechnology firm. The alliance focuses on the development and licensing of high-value APIs using Willow’s AI-driven bioengineering platform. The strategic partnership includes
Charles River Laboratories has launched two new frameworks for viral vector technology transfer, named Modular and Fast Track. These frameworks are designed to facilitate the continuity of product development through a seamless process transfer to the company’s Maryland-based viral vector
Enzene Biosciences has announced the launch of its new Drug Discovery Division. This move is set to enhance the company’s contract service offerings and address the increasing demands of the biopharmaceutical sector. The newly established division will be housed within Enzene’s
Sterling Pharma Solutions has announced a significant investment to enhance its antibody-drug conjugate (ADC) contract development and manufacturing services. The $3 million investment at the Germantown, WI facility aims to expand the company’s integrated ADC capabilities, marking a substantial step
UniD Manufacturing are the first global Contract Development and Manufacturing Organization (CDMO) fully dedicated to micro-implants based on sustained release and polymeric formulations. 2024 is an important year for UniD Manufacturing, their first as a CDMO open to external customers,
Eurofins CDMO Alphora Inc., a Contract Development & Manufacturing Organization (CDMO), has recently announced a substantial expansion of its Drug Product Analytical Services Laboratory. This development has tripled the facility’s size, located in Mississauga, Canada, and marks a significant stride
In a significant advancement for pharmaceutical packaging, West Pharmaceutical Services, Inc. has introduced its latest innovation – the Daikyo Crystal Zenith (CZ) Nested Vials in Tub. This product is set to redefine the standards for storing sensitive treatments, particularly in the cell
Asahi Kasei Medical has announced the completion of its third assembly plant for Planova virus removal filters, located in Nobeoka, Miyazaki, Japan. This strategic move is set to bolster the company’s capacity to meet the surging global demand for these essential
The biologics market for inflammatory bowel disease (IBD) is rapidly evolving, with significant developments and increasing competition driving the field forward. June Seow, MPharm Senior Business Analyst for Lifescience Dynamics explains key trends shaping the market. Biologics Leading the Charge
Eli Lilly has announced a new $5.3 billion investment in its manufacturing site in Lebanon, Indiana, US. This investment increases the firm’s total investment in the site from $3.7 billion to $9 billion. The expansion will increase the manufacturing capacity
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
